Kenvue Inc. (NYSE:KVUE) is one of the best large cap stocks to buy under $50. Jefferies downgraded Kenvue to Hold from Buy on Jan 30, lowering the price target to $18. Shareholders of Kimberly-Clark and Kenvue approved the acquisition, with 96% of Kimberly-Clark shares and 99% of Kenvue’s voting shares in favor.

CEOs express confidence in the creation of a global health and wellness leader through the merger of Kimberly-Clark and Kenvue. The transaction is expected to close in H2 2026, pending final regulatory approvals. Kenvue operates as a consumer health company with three segments: Self Care, Skin Health and Beauty, and Essential Health.

While Kenvue shows investment potential, certain AI stocks may offer greater upside with less downside risk. For an undervalued AI stock benefiting from Trump-era tariffs, read Insider Monkey’s report on the best short-term AI stock. No promotional content is included in this news article.

Read more at Yahoo Finance: Jefferies Downgrades Kenvue (KVUE) to Hold With $18 PT Over Limited Upside, Litigation Risks